These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1966110)

  • 41. Evaluation of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, in experimental intimal hyperplasia.
    Levitt MA; Dryjski M; Tluczek J; Bjornsson TD
    Prostaglandins; 1991 Jan; 41(1):1-6. PubMed ID: 1708508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergism between superoxide dismutase and sodium nitrite in cardioprotection following ischemia and reperfusion.
    Johnson G; Tsao P; Lefer AM
    Am Heart J; 1990 Mar; 119(3 Pt 1):530-7. PubMed ID: 2155521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Griswold DE; Egan JW; Earl CQ; Hillegass LM; Marshall PJ; Smith EF
    Prog Clin Biol Res; 1989; 301():161-5. PubMed ID: 2529547
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
    Pill J; Metz J; Stegmeier K; Hartig F
    Agents Actions Suppl; 1992; 37():107-13. PubMed ID: 1632287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion.
    Hock CE; Beck LD; Papa LA
    Cardiovasc Res; 1992 Dec; 26(12):1206-11. PubMed ID: 1337729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban.
    Pill J; Wolf O; Schmelz A; Stegmeier K; Metz J
    Z Kardiol; 1990; 79 Suppl 3():155-60. PubMed ID: 2151550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Deodato B; Arlotta M; Minutoli L; Quartarone C; Ferlito M; Caputi AP
    J Mol Cell Cardiol; 2000 Mar; 32(3):429-40. PubMed ID: 10731442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs.
    Yoo KY; Yang SY; Lee J; Im WM; Jeong CY; Chung SS; Kwak SH
    Br J Anaesth; 1999 Jan; 82(1):90-6. PubMed ID: 10325843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion.
    Hayward R; Nossuli TO; Scalia R; Lefer AM
    Eur J Pharmacol; 1997 Sep; 334(2-3):157-63. PubMed ID: 9369344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
    Löbel P; Schrör E; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of thromboxane A2 in myocardial ischemia and circulatory shock.
    Lefer AM
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():321-6. PubMed ID: 2526491
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
    Osborne JA; Lefer AM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
    Ioculano M; Squadrito F; Altavilla D; Canale P; Campo GM; Bussolino F; Sardella A; Urna G; Caputi AP
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):7-12. PubMed ID: 7511738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.